Sharples LD - Search Results

1

Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment.

Smyth RL, Scott JP, Borysiewicz LK, Sharples LD, Stewart S, Wreghitt TG, Gray JJ, Higenbottam TW, Wallwork J. Smyth RL, et al. Among authors: sharples ld. J Infect Dis. 1991 Dec;164(6):1045-50. doi: 10.1093/infdis/164.6.1045. J Infect Dis. 1991. PMID: 1659595

2

Risk factors for survival following combined heart-lung transplantation. The first 100 patients.

Sharples LD, Scott JP, Dennis C, Higenbottam TW, Stewart S, Wreghitt T, Large SR, Wells FC, Wallwork J. Sharples LD, et al. Transplantation. 1994 Jan;57(2):218-23. doi: 10.1097/00007890-199401001-00011. Transplantation. 1994. PMID: 8310511

3

Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.

Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J. Sharples LD, et al. Transplantation. 1996 Feb 27;61(4):560-6. doi: 10.1097/00007890-199602270-00008. Transplantation. 1996. PMID: 8610381

4

Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.

Sharples LD, Jackson CH, Parameshwar J, Wallwork J, Large SR. Sharples LD, et al. Transplantation. 2003 Aug 27;76(4):679-82. doi: 10.1097/01.TP.0000071200.37399.1D. Transplantation. 2003. PMID: 12973108

5

Bronchiolitis obliterans syndrome: risk factors and therapeutic strategies.

Scott AI, Sharples LD, Stewart S. Scott AI, et al. Among authors: sharples ld. Drugs. 2005;65(6):761-71. doi: 10.2165/00003495-200565060-00004. Drugs. 2005. PMID: 15819589 Review.

6

Risk factors for bronchiolitis obliterans: a systematic review of recent publications.

Sharples LD, McNeil K, Stewart S, Wallwork J. Sharples LD, et al. J Heart Lung Transplant. 2002 Feb;21(2):271-81. doi: 10.1016/s1053-2498(01)00360-6. J Heart Lung Transplant. 2002. PMID: 11834356 Review.

7

Efficacy of pyrimethamine for the prevention of donor-acquired Toxoplasma gondii infection in heart and heart-lung transplant patients.

Wreghitt TG, Gray JJ, Pavel P, Balfour A, Fabbri A, Sharples LD, Wallwork J. Wreghitt TG, et al. Among authors: sharples ld. Transpl Int. 1992 Sep;5(4):197-200. doi: 10.1007/BF00336069. Transpl Int. 1992. PMID: 1418309

8

Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease.

Sharples LD, Caine N, Mullins P, Scott JP, Solis E, English TA, Large SR, Schofield PM, Wallwork J. Sharples LD, et al. Transplantation. 1991 Aug;52(2):244-52. doi: 10.1097/00007890-199108000-00012. Transplantation. 1991. PMID: 1871797

9

Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation.

Caine N, Sharples LD, Smyth R, Scott J, Hathaway T, Higenbottam TW, Wallwork J. Caine N, et al. Among authors: sharples ld. Transplant Proc. 1991 Feb;23(1 Pt 2):1203-4. Transplant Proc. 1991. PMID: 1989186 No abstract available.

10

Donor and recipient predicted lung volume and lung size after heart-lung transplantation.

Tamm M, Higenbottam TW, Dennis CM, Sharples LD, Wallwork J. Tamm M, et al. Among authors: sharples ld. Am J Respir Crit Care Med. 1994 Aug;150(2):403-7. doi: 10.1164/ajrccm.150.2.8049822. Am J Respir Crit Care Med. 1994. PMID: 8049822

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters